Repurposing Diflunisal for Familial Amyloid Polyneuropathy
John L. Berk(Boston University), P. James B. Dyck(Mayo Clinic), Michael A. Heneghan(King's College London), Peter D. Gorevic(Université Paris-Sud), Denis Rybin(Boston University), David C. Seldin(Boston University), William J. Litchy(Mayo Clinic), Janice F. Wiesman(Boston University), Theodore Colton(Cosmos Corporation (United States)), M. Di Corato(Fondazione Humanitas per la Ricerca), Yoshiki Sekijima(Shinshu University), Erik Nordh(Umeå University), Steven R. Zeldenrust, Alessandro Lozza(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Laura Obici(University of Pavia), Jessica Robinson‐Papp(Icahn School of Medicine at Mount Sinai), Jeffery W. Kelly(Scripps Research Institute), Giampaolo Merlini(University of Pavia), Ole B. Suhr(Umeå University), Alice Bisbee(Boston University), Taro Yamashita(Kumamoto University), Shu-ichi Ikeda(Ōtani University), Martha Skinner(Boston University), Andrea Cortese(University of Pavia)
Cited by 701
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k